Literature DB >> 17327792

Extradural transcavernous approach to cavernous sinus hemangiomas.

Ashish Suri1, Faiz U Ahmad, Ashok K Mahapatra.   

Abstract

OBJECTIVE: Cavernous sinus hemangiomas (CSHs) are uncommon lesions and comprise fewer than 1% of all parasellar masses. Because of their location, propensity for profuse bleeding during surgery, and relationship to complex neurovascular structures, they are notoriously difficult to excise. CLINICAL
PRESENTATION: The authors describe their experience with seven cases of CSHs. Headache and visual impairment were the most common presenting complaints, followed by facial hypesthesia and diplopia. Computed tomographic scans revealed iso- to hyperdense expansile lesions in the region of the cavernous sinus and middle cranial fossa. Magnetic resonance imaging scans revealed hypo- to isointense lesions on T1-weighted images and markedly hyperintense lesions on T2-weighted images, with marked homogeneous enhancement after contrast administration. INTERVENTION: All CSHs were treated by a purely extradural transcavernous approach. This involved reduction of sphenoid ridge, exposure of the superior orbital fissure, drilling of the anterior clinoid process, coagulation and division of the middle meningeal artery, and peeling of the meningeal layer of the lateral wall of the cavernous sinus from the inner membranous layer. The cranial nerves in the lateral wall of the cavernous sinus were exposed (Cranial Nerves III and IV, as well as V1, V2, and V3). The tumor was accessed through its maximum bulge through either the lateral or anterolateral triangle. The tumor was removed via rapid decompression, coagulation of the feeder from the meningohypophyseal trunk, and dissection along the cranial nerves. All but one patient had complete tumor excision. Transient ophthalmoparesis (complete resolution in 6-8 wk) was the most common surgical complication.
CONCLUSION: To our knowledge, we describe one of the largest series of pure extradural transcavernous approaches to CSHs. CSHs are uncommon but challenging cranial base lesions. The extradural transcavernous approach allows complete excision with minimal mortality or long-term morbidity.

Entities:  

Mesh:

Year:  2007        PMID: 17327792     DOI: 10.1227/01.NEU.0000255333.95532.13

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Dynamic enhancement features of cavernous sinus cavernous hemangiomas on conventional contrast-enhanced MR imaging.

Authors:  Y Jinhu; D Jianping; L Xin; Z Yuanli
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-07       Impact factor: 3.825

Review 2.  The role of stereotactic radiosurgery in cavernous sinus hemangiomas: a systematic review and meta-analysis.

Authors:  Xin Wang; Guanghai Mei; Xiaoxia Liu; Jiazhong Dai; Li Pan; Enmin Wang
Journal:  J Neurooncol       Date:  2011-11-16       Impact factor: 4.130

3.  Cavernous Sinus Vascular Venous Malformation.

Authors:  J C Benson; K L Eschbacher; A Raghunathan; D Johnson; D K Kim; J Van Gompel
Journal:  AJNR Am J Neuroradiol       Date:  2021-11-11       Impact factor: 3.825

4.  Transnasal endoscopic resection of a cavernous sinus hemangioma: technical note and review of the literature.

Authors:  Justin F Fraser; Alon Y Mass; Seth Brown; Vijay K Anand; Theodore H Schwartz
Journal:  Skull Base       Date:  2008-09

5.  Hemangioma of the Cavernous Sinus: A Case Series.

Authors:  Dylan A Noblett; Jennifer Chang; Atrin Toussi; Arthur Dublin; Kiarash Shahlaie
Journal:  J Neurol Surg Rep       Date:  2018-04-26

6.  Therapeutic Effect of Hypofractionated Stereotactic Radiotherapy Using CyberKnife for High Volume Cavernous Sinus Cavernous Hemangiomas.

Authors:  Lichao Huang; Lu Sun; Weijun Wang; Zhiqiang Cui; Zizhong Zhang; Jiwei Li; Yao Wang; Jinyuan Wang; Xinguang Yu; Zhipei Ling; Baolin Qu; Long Sheng Pan
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

Review 7.  Intracranial Anatomical Triangles: A Comprehensive Illustrated Review.

Authors:  Doniel Drazin; Joy Mh Wang; Fernando Alonso; Daxa M Patel; Andre Granger; Mohammadali M Shoja; Marios Loukas; Rod J Oskouian; R Shane Tubbs
Journal:  Cureus       Date:  2017-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.